Introduction {#s1}
============

The management of pain has always been one of the greatest medical challenges. The International Association for the Study of Pain described it as an unpleasant sensory or emotional experience combined with possible or actual tissue damage, or reported while tissues are being damaged.[@R1] Pain is a physiological symptom which acts as a warning and informs the body about damage or illness, and is therefore essential for life.

Surgical patients are one of the largest group of individuals to experience pain, which is directly related to their treatment. Proper management of postoperative pain allows wounds to heal faster and the patient to recover more quickly. Similarly in child birth, proper administration of analgesia reduces pain and makes delivery less stressful.[@R2] [@R3]

Continuous analgesia with a mixture of opioids and local anaesthetics is becoming increasingly common for pain management in patients after surgery. It is safe and very effective, and can be successfully used even after severe and extensive abdominal or thoracic interventions.[@R4] [@R5] Such mixtures are also frequently used in short term analgesia for labour and caesarean section.[@R6]

Despite great progress in continuous epidural analgesia using mixtures of opioids and local anaesthetics, there are no fast and precise methods to determine the stability and physicochemical safety of such mixtures.

The aim of this study was to develop and validate an HPLC method with UV detection to determine the stability of mixtures of fentanyl citrate and bupivacaine hydrochloride in standard infusion solutions of 0.9% NaCl and 5% glucose.

Experimental {#s2}
============

Materials and reagents {#s3}
----------------------

Bupivacaine hydrochloride standard was obtained from Sigma-Aldrich (Munich, Germany), while 50 µg/ml fentanyl citrate and 0.5% bupivacaine hydrochloride solutions were obtained from WZF Polfa (Warsaw, Poland) together with fentanyl citrate standard. All others chemicals were obtained from POCh (Gliwice, Poland) and were of HPLC or analytical grade.

Equipment {#s4}
---------

A Shimadzu chromatographic system (Shimadzu, Kyoto, Japan) consisting of a Shimadzu LC-20AT pump, Shimadzu SPD-20A UV-Vis detector, Shimadzu CTO-10AS UP column thermostat, 20 µl Berkeley 7725i rheodyne and ChroMax 2006 software was used.

Chromatographic conditions {#s5}
--------------------------

A LiChrospher 100 CN, 250×4 mm, 10 µm particle size (Merck, Darmstadt, Germany) column was used. The final composition of the mobile phase was a mixture of acetonitrile and 0.01 M phosphate buffer at pH 2.81 (3:7, V/V) with addition of 0.08 g/l potassium chloride. The flow rate was 1.5 ml/min, with detection at UV wavelength 210 nm. The column was kept at 30°C and the injection volume was 20 µl.

Method validation {#s6}
-----------------

The method was validated according to the guideline of the International Conference on Harmonization.[@R7] Microsoft Excel 2007 was used to calculate the method parameters.

Selectivity {#s7}
-----------

The selectivity of the method was examined for samples after preparation and for samples after approximately 72 h storage at room temperature, after the addition of procaine hydrochloride as an internal standard.

Linearity {#s8}
---------

P~fent~/P~IS~=f(c) and P~bupi~/P~IS~ calibration plots for aqueous solutions of fentanyl citrate and bupivacaine hydrochloride were obtained in the concentration range (2.50--7.52) µg/10 ml for fentanyl citrate and (0.059--0.1770) mg/10 ml for bupivacaine hydrochloride, where P~fent~/P~IS~ and P~bupi~/P~IS~ are fentanyl/bupivacaine to procaine hydrochloride (internal standard, IS) peak area ratios. Samples of each solution were injected three times. Calibration curves for an average of each concentration were obtained; each series consisted of five experimental points.

Precision {#s9}
---------

The precision of the method was determined in relation to repeatability (intra-day). In order to evaluate the repeatability of the method, six samples of bupivacaine hydrochloride solution and fentanyl citrate solution, with the addition of procaine hydrochloride solution as an internal standard, were analysed on the same day. The concentrations of the samples were 111 mg/10 ml for bupivacaine hydrochloride and 0.005 mg/10 ml for fentanyl citrate.

The intermediate precision of the method was also evaluated. In order to evaluate this, samples prepared as before were analysed over the following 2 days.

Accuracy {#s10}
--------

The accuracy of the method was calculated as a percentage recovery x~i~/µ×100%, where x~i~ is the analysed amount of either fentanyl citrate or bupivacaine hydrochloride in the sample, and µ is the known amount of the substance in the sample. To do so, standard solutions of bupivacaine hydrochloride and fentanyl citrate, and two solutions of drugs containing fentanyl citrate and bupivacaine hydrochloride were prepared, where solutions of the drugs were planned to contain 100% and 80% of the concentration of the standard solutions of each substance, respectively.

Limits of detection (LOD) and quantification (LOQ) {#s11}
--------------------------------------------------

The LOD and LOQ of fentanyl citrate and bupivacaine hydrochloride were calculated from the regression equation as 3.3 Sy/a and 10 Sy/a, respectively, where Sy is the SD and a denotes the slope of the corresponding calibration curve.

Stability studies {#s12}
-----------------

Stability studies were performed for mixtures of fentanyl citrate and bupivacaine hydrochloride prepared in solutions of 0.9% NaCl and 5% glucose (B Braun, Melsungen, Germany). From 100 ml bottles of infusion solutions, 30 ml were removed using a Mini Spike system and replace with 20 ml of 0.5% bupivacaine hydrochloride solution and 10 ml of 50 µg/ml fentanyl citrate solution. Bottles with infusion solutions were incubated at 25°C for 15 min prior to addition of the drugs. The prepared mixtures were kept at 25°C for 72 h. At specified intervals, 2 ml samples were taken from the solutions and 1.0 ml from those samples were mixed with 0.2 ml of the internal standard solution. Then, 20 µl of the prepared sample were injected onto the column. In this study solutions of fentanyl citrate and bupivacaine hydrochloride were defined as stable when the substrate loss was not greater than 5% relative to the initial value.

Results and discussion {#s13}
======================

Chromatographic conditions {#s14}
--------------------------

Selection of the appropriate chromatographic conditions for the determination of the fentanyl citrate and bupivacaine hydrochloride mixtures in standard infusion solutions of 0.9% NaCl and 5% glucose, was based on a literature review of methods for the determination of those substances. The literature recommends using CN-filled columns. Optimal separation of fentanyl citrate and bupivacaine hydrochloride is possible at 15%--40% concentration of the organic component in the mobile phase. It is suggested that the inorganic component should have pH ≤ 5.[@R8]--[@R13] UV detection at λ=210 nm was selected as it is the absorbance maximum for fentanyl citrate present in the solution at a concentration 200 times lower than that of bupivacaine hydrochloride, which poses a considerable analytical problem.

To optimise the chromatographic conditions, the influence of three parameters was assessed: Acetonitrile concentrationFlow rateConcentration of potassium chloride in the mobile phase.

### Influence of acetonitrile concentration {#s15}

Based on the literature, the mobile phase contained acetonitrile and 0.01 M phosphate buffer (pH 2.81). The concentrations of acetonitrile in the mobile phase were 20%, 25%, 30% and 35%. Results obtained using the chromatographic conditions presented in the Chromatographic conditions section are shown in [figure 1](#F1){ref-type="fig"} and [table 1](#T1){ref-type="table"}.

![Comparison of mobile phases with different acetonitrile (ACN) concentrations.](ejhpharm-2012-000088fig1){#F1}

###### 

Comparison of the influence of acetonitrile (ACN) concentration on chromatographic parameters

        Retention time   Peak symmetry          
  ----- ---------------- --------------- ------ ------
  20%   13.32            26.61           4.76   2.17
  25%   11.83            20.86           4.21   1.96
  30%   10.42            16.26           3.51   1.73
  35%   10.36            15.98           3.34   1.66

Based on those results, the mobile phase with 30% acetonitrile (ACN) was chosen for further method development. The lower ACN concentrations led to lower peak symmetry factors and longer retention times. As the difference between 30% and 35% ACN is not significant, the former was chosen as optimal.

### Influence of flow rate {#s16}

To optimise the flow rate of the mobile phase, four flow rates were analysed: 1.0 ml/min, 1.2 ml/min, 1.5 ml/min and 1.7 ml/min. The results are shown in [figure 2](#F2){ref-type="fig"} and [table 2](#T2){ref-type="table"}. The 1.5 ml/min flow rate was chosen for further study. As the difference between the 1.7 and 1.5 ml/min flow rates is not significant, the latter was selected to avoid problems with the internal standard.

![Comparison of different flow rates.](ejhpharm-2012-000088fig2){#F2}

###### 

Comparison of the influence of flow rate on chromatographic parameters

               Retention time   Peak symmetry          
  ------------ ---------------- --------------- ------ ------
  1.0 ml/min   14.66            22.78           2.96   1.65
  1.2 ml/min   12.19            18.92           2.93   1.64
  1.5 ml/min   9.81             15.46           2.72   1.73
  1.7 ml/min   8.63             13.33           2.67   1.57

### Influence of potassium chloride on chromatographic conditions {#s17}

To improve the quality of chromatographic separation, the influence of potassium chloride on the mobile phase was investigated. A mobile phase containing 0.08 g/l of potassium chloride was prepared and the results were compared with those obtained without potassium chloride ([table 3](#T3){ref-type="table"}).

###### 

Influence of potassium chloride on chromatographic separation

                              Retention time   Peak symmetry          
  --------------------------- ---------------- --------------- ------ ------
  30% ACN                     10.15            15.46           3.51   1.73
  30% ACN with 0.08 g/l KCl   9.77             15.10           3.38   1.70

ACN, acetonitrile.

The presence of potassium chloride has a positive effect on the chromatographic separation of bupivacaine and fentanyl.

Method validation {#s18}
-----------------

### Selectivity and selection of internal standard {#s19}

In order to avoid injection mistakes, an internal standard -- procaine hydrochloride -- was used. The retention times for substances were: procaine hydrochloride ∼5 min, bupivacaine hydrochloride ∼10 min and fentanyl citrate ∼15 min. The HPLC method for the determination of bupivacaine and fentanyl was found to be selective in the presence of the internal standard.

### Linearity {#s20}

Linearity was determined separately for bupivacaine hydrochloride and fentanyl citrate. The concentration range was 50%--150% of the concentration of those drugs used in clinical practice: 0.0172--0.0516 mol/l for bupivacaine hydrochloride and 0.473--1.42 mmol/l for fentanyl citrate. Both calibration plots were linear and were described by the equation y=ax; values b calculated from the equation y=ax+b were statistically insignificant, as they were lower than the critical value tb=b/Sb. ([table 4](#T4){ref-type="table"}).

###### 

Statistical parameters for linearity of bupivacaine hydrochloride and fentanyl citrate

  Bupivacaine hydrochloride   Fentanyl citrate
  --------------------------- ------------------
  y=ax±b                      y=ax±b
  a±Δa=53134±0.521            a±Δa=0.031±0.002
  b±Δb=0.015±0.065            b±Δb=0.006±0.008
  Sa=0.246                    Sa=0.001
  Sb=0.030                    Sb=0.004
  Sy=0.040                    Sy=0.005
  Ta=216184                   Ta=43 313
  Tb=0.476                    Tb=1542
  R=0.9998                    R=0.9958
  y=ax                        y=ax
  a±Δa=53245±0.505            a±Δa=0.033±0.001
  Sa=0.238                    Sa=0.001
  Sy=0.039                    Sy=0.005
  r=0.9998                    r=0.9958

S is SD and T is variance.

Precision, accuracy, LOD and LOQ {#s21}
--------------------------------

### Precision {#s22}

To establish precision, the method repeatability of the method was determined. Six samples of the same concentration of both bupivacaine hydrochloride and fentanyl citrate were prepared and injected onto the column. The results are shown in [table 5](#T5){ref-type="table"}.

###### 

Method precision for bupivacaine hydrochloride and fentanyl citrate

  --------------------------------- --------------
  Bupivacaine hydrochloride         
   Average                          6.2635
   Variance: s^2^                   1.89×10^--3^
   SD: s                            0.04354
   Relative SD: S^y^                0.00695
   Coefficient of variation: W^z^   0.70%
  Fentanyl citrate                  
   Average                          0.1666
   Variance: s^2^                   8.63×10^--6^
   SD: s                            0.00294
   Relative SD: S^y^                0.01763
   Coefficient of variation: W^z^   1.76%
  --------------------------------- --------------

Intermediate precision was also established in the same way as repeatability, but samples were injected twice onto the column on 2 different days ([table 6](#T6){ref-type="table"}).

###### 

Intermediate method precision for bupivacaine hydrochloride and fentanyl citrate

  --------------------------------- --------------
  Bupivacaine hydrochloride         
   Average                          6.3284
   Variance: s^2^                   6.27×10^--3^
   SD: s                            0.0792
   Relative SD: s^y^                0.0125
   Coefficient of variation: W^z^   1.25%
  Fentanyl citrate                  
   Average                          0.1665
   Variance: s^2^                   6.38×10^--6^
   SD: s                            0.0025
   Relative SD: s^y^                0.0152
   Coefficient of variation: W^z^   1.52%
  --------------------------------- --------------

Results show that the method has good precision.

### Accuracy {#s23}

Method accuracy is defined as recovery percentage (x~i~/µ×100%, where x~i~ is the analysed amount of either fentanyl citrate or bupivacaine hydrochloride in the sample, and µ is the known amount of the substance in the sample). Standard solutions of bupivacaine hydrochloride and fentanyl citrate were prepared and two solutions of each substance at drug concentrations 100% and 80% of the standard solution.

### Limits of detection and quantification {#s24}

The LOD and LOQ for fentanyl citrate and bupivacaine hydrochloride were calculated from the regression equations 3,3 Sy/a and 10 Sy/a, respectively, where Sy is the SD and a denotes the slope of the corresponding calibration curve ([table 7](#T7){ref-type="table"}).

###### 

Validation parameters of the method for bupivacaine hydrochloride and fentanyl citrate

  Parameter                Bupivacaine          Fentanyl
  ------------------------ -------------------- -----------------
  Linearity range          0.059--0.177 mg/ml   2.5--7.25 μg/ml
  LOD                      2.47×10^--3^ mg/ml   0.5 μg/ml
  LOQ                      7.5×10^--3^ mg/ml    1.5 μg/ml
  Repeatability            0.70%                1.76%
  Intermediate precision   1.25%                1.52%
  Percentage recovery      99.02%               104.53%

LOD, limit of detection; LOQ, limit of quantification.

Stability studies {#s25}
-----------------

The results of stability studies are presented in [tables 8](#T8){ref-type="table"} and [9](#T9){ref-type="table"}. As the results show that neither of the solution concentrations falls below the 95% starting concentration limit, we considered both solutions stable. This corresponds with previous studies.[@R10] [@R12] [@R14]

###### 

Stability of bupivacaine hydrochloride and fentanyl citrate in 0.9% NaCl, 25°C

  Sample           t (h)                       P~IS~              PBup       P~fent~   PBup/P~IS~   %B        P~fent~/P~IS~   %F
  ---------------- --------------------------- ------------------ ---------- --------- ------------ --------- --------------- ---------
  1                0                           888999             30473943   171402    342789       100.00%   0.1928          100.00%
  2                1                           870079             29416332   164967    338088       98.63%    0.1896          98.34%
  3                6.5                         785461             27937316   154065    355680       103.76%   0.1961          101.73%
  4                23                          862758             29865464   167883    346163       100.98%   0.1946          100.93%
  5                32.5                        544133             19132839   106660    351621       102.58%   0.1960          101.67%
  6                47                          889441             30055613   166951    337916       98.58%    0.1877          97.35%
  7                51.5                        605950             21098765   118155    348193       101.58%   0.1950          101.13%
  8                72                          881896             29663404   166695    336359       98.12%    0.1890          98.04%
                   Bupivacaine hydrochloride   Fentanyl citrate                                                               
  Average amount   100.53%                     99.89%                                                                         
  SD               2.05                        1.75                                                                           

###### 

Stability of bupivacaine hydrochloride and fentanyl citrate in 5% glucose, 25°C

  Sample           t (h)                       P~IS~              PBup       P~fent~   PBup/P~IS~   %B        P~fent~/P~IS~   %F
  ---------------- --------------------------- ------------------ ---------- --------- ------------ --------- --------------- ---------
  1                0                           927521             28908568   155979    3116756      100.00%   0.1681          100.00%
  2                1                           890054             28720334   150732    3226808      103.53%   0.1693          100.70%
  3                6.5                         808511             25436765   137987    3146125      100.94%   0.1706          101.49%
  4                23                          904547             28270820   156270    3125412      100.28%   0.1727          102.73%
  5                24                          909636             28961765   160160    3183885      102.15%   0.1760          104.70%
  6                47                          999233             30018765   164415    3004181      96.39%    0.1645          97.84%
  7                48                          898613             28241824   155028    3142824      100.84%   0.1725          102.59%
  8                72                          921833             28846309   155120    3129234      100.40%   0.1682          100.06%
                   Bupivacaine hydrochloride   Fentanyl citrate                                                               
  Average amount   100.57%                     101.26%                                                                        
  SD               2.05                        2.10                                                                           

Conclusion {#s26}
==========

The proposed method was proved to be suitable for determining the stability of fentanyl citrate and bupivacaine hydrochloride mixtures in standard intravenous fluids. It may be applied to establish the stability of drug mixtures prepared in the hospital pharmacy using an automatic BAXA compounder. Further studies on fentanyl and bupivacaine regarding the microbiological purity of their mixtures are necessary.
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